Edinburgh Molecular Imaging (EM Imaging) is a clinical phase biotechnology company focused on enabling image-guided therapy. The company has a portfolio of agents with the most advanced cancer detection currently under Phase IIb clinical study

RoslinCT is a Contract Development and Manufacturing Organisation (CDMO) offering process development, technology transfer, GMP manufacture and batch release of cell-based therapies and Advanced Therapy Medicinal Products (ATMPs) for clinical trials in Europe and the US.

LifeArc® pioneers new ways to turn great science into greater patient impact, helping scientists and organisations advance research into therapeutics and diagnostics. Successes include Keytruda®(cancer) and an antimicrobial resistance test.

Aquila BioMedical is an innovative, pre-clinical CRO, offering clients world-leading tailored research expertise in Immuno-Oncology, Immunology, Immuno-Oncology, Regeneration and specialist multiplex Histology.

The Directorate of Laboratory Medicine provides laboratory services to primary and secondary care within and beyond Lothian. The laboratories perform more than 13 million tests per year and employ over 600 staff.

The CALCIVIS imaging system uses a photoprotein to detect free calcium ions on tooth surfaces and provides practitioners with a visual map of active demineralisation. This innovative device supports the preventive, minimally invasive approach and is set to revolutionise dentistry around the world.

Recircle is an industrial biotechnology company that harnesses nature to deliver clean and renewable solutions for major industrial needs.

Research Support Office offer specialist knowledge and targeted support to the University of Edinburgh’s research community across the research lifecycle and particularly in the pursuit of funding.